Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Exelixis expands cabozantinib development program

May 7, 2012

Abbott to acquire melanocortin receptor agonist

May 7, 2012

Caisson Biotech forms licensing agreement with Novo Nordisk

May 4, 2012

Dako and Genentech to collaborate on U.S. regulatory submissions for companion diagnostics

May 3, 2012

Genomic Health and OncoMed form alliance

May 3, 2012

Quark to conduct phase IIa study of siRNA drug in open-angle glaucoma

May 3, 2012

Altor BioScience product to enter clinical testing for melanoma

May 3, 2012

Trevena enters collaboration to identify novel biased ligand molecules

May 3, 2012

AnaptysBio and Gilead Sciences sign antibody discovery partnership

May 2, 2012

Tolero and MannKind enter agreement for BTK inhibitors

May 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...